News
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).
Biographical series in which guests choose someone who has inspired their lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results